Mycosis fungoides and the SĂ©zary syndrome
Foss F. Mycosis fungoides and the SĂ©zary syndrome. Current Opinion In Oncology 2004, 16: 421-428. PMID: 15314509, DOI: 10.1097/00001622-200409000-00002.Peer-Reviewed Original ResearchMeSH KeywordsAnticarcinogenic AgentsBexaroteneHumansMycosis FungoidesNeoplasm StagingPrognosisSezary SyndromeSkin NeoplasmsTetrahydronaphthalenesConceptsEarly-stage patientsSĂ©zary syndromeMycosis fungoidesTreatment paradigmPeptide-loaded dendritic cellsEvolution of immunotherapyUse of photopheresisClinical prognostic factorsNucleoside analogue therapyReceptor-directed therapyT cell responsesTreatment of patientsNon-Hodgkin lymphomaNovel treatment optionsFurther clinical evaluationNovel therapeutic approachesHistone deacetylase inhibitorsWorld Health OrganizationAnalogue therapySystemic therapyClinical stagingDendritic cellsPrognostic factorsSĂ©zary cellsClinical entity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply